CARM1 and Miyoshi myopathy: Specifically, we show synergistic interaction between CARM1 inhibition and IMiD treatment against MM, and we demonstrate that this synergy can be mimicked by a novel, rationally developed small molecule inhibitor composed of a CARM1 inhibitor and IMiD.